Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-22

FDA Approved: TIOPRONIN — Original Application (Teva Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Teva's original application for Tiopronin as a generic drug for the treatment of cystinuria to prevent kidney stone formation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tiopronin (Tiopronin)

Snippet

ORIG AP for TIOPRONIN (TIOPRONIN)